Our previous studies have shown that the expression of PD-L1 and OPN is regulated by the WDR5/MLL1-H3K4me3 pathway [18,19], and WDR5-47 effectively improved anti-PD-L1 efficacy in pancreatic tumor [18]. Here, KMT2A is linked to pancreatic neoplasm.